Label: BHI SINUS- euphorbia resinifera resin, goldenseal, potassium dichromate, potassium iodide, phosphorus, pulsatilla vulgaris, and thuja occidentalis leafy twig tablet

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved homeopathic

DISCLAIMER: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.

Drug Label Information

Updated August 8, 2022

If you are a consumer or patient please visit this version.

View All Sections
  • ACTIVE INGREDIENTS

    Each tablet contains: *Euphorbium officinarum 6X, *Hydrastis canadensis 6X, Kali bichromicum 6X, Kali iodatum 8X, *Phosphorus 8X, *Pulsatilla 4X, *Thuja occidentalis 6X 42.9 mg each.

    *Natural Ingredients

  • INACTIVE INGREDIENTS

    Inactive Ingredients: Dextrose,  Magnesium Stearate, Maltodextrin

  • PURPOSE

    Sinus Relief Tablets

    Relieves:

    • Nasal Congestion

    • Sinus Headache & Pressure

    • Cold/Flu Nasal Symptoms

  • USES

    For the temporary relief of minor sinus congestion and pressure due to allergic rhinitis and colds

  • Directions

    At first sign of symptoms: Adults and children 4 years and older: 1 tablet every 1/2 to 1 hour until symptoms lessen, then continue with standard dosage. 

    Standard dosage: Adults and children 4 years and older: Take 1-2 tablet every 4 to 6 hours. Do not exceed 12 tablets in 24 hours. For children under 4, consult your health professional.

    Allow tablets to dissolve completely in the mouth, do not swallow.

  • WARNINGS

    If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. If symptoms persist or worsen, a health professional should be consulted. Do not use if known sensitivity to BHI Sinus or any of its ingredients exists.

  • KEEP OUT OF REACH OF CHILDREN

    Keep out of reach of children.

  • PRINCIPAL DISPLAY PANEL

    BHI Sinus Tablet

    Add image transcription here...

  • INGREDIENTS AND APPEARANCE
    BHI SINUS 
    euphorbia resinifera resin, goldenseal, potassium dichromate, potassium iodide, phosphorus, pulsatilla vulgaris, and thuja occidentalis leafy twig tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:62795-1017
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    EUPHORBIA RESINIFERA RESIN (UNII: 1TI1O9028K) (EUPHORBIA RESINIFERA RESIN - UNII:1TI1O9028K) EUPHORBIA RESINIFERA RESIN6 [hp_X]
    GOLDENSEAL (UNII: ZW3Z11D0JV) (GOLDENSEAL - UNII:ZW3Z11D0JV) GOLDENSEAL6 [hp_X]
    POTASSIUM DICHROMATE (UNII: T4423S18FM) (DICHROMATE ION - UNII:9LKY4BFN2V) POTASSIUM DICHROMATE6 [hp_X]
    POTASSIUM IODIDE (UNII: 1C4QK22F9J) (IODIDE ION - UNII:09G4I6V86Q) IODIDE ION8 [hp_X]
    PHOSPHORUS (UNII: 27YLU75U4W) (PHOSPHORUS - UNII:27YLU75U4W) PHOSPHORUS8 [hp_X]
    PULSATILLA VULGARIS (UNII: I76KB35JEV) (PULSATILLA VULGARIS - UNII:I76KB35JEV) PULSATILLA VULGARIS4 [hp_X]
    THUJA OCCIDENTALIS LEAFY TWIG (UNII: 1NT28V9397) (THUJA OCCIDENTALIS LEAFY TWIG - UNII:1NT28V9397) THUJA OCCIDENTALIS LEAFY TWIG6 [hp_X]
    Inactive Ingredients
    Ingredient NameStrength
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    MALTODEXTRIN (UNII: 7CVR7L4A2D)  
    DEXTROSE (UNII: IY9XDZ35W2)  
    Product Characteristics
    ColorwhiteScoreno score
    ShapeROUNDSize9mm
    FlavorImprint Code Leafman
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:62795-1017-31 in 1 CARTON01/01/2015
    1100 in 1 BOTTLE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved homeopathic01/01/2015
    Labeler - MediNatura Inc (079324099)
    Establishment
    NameAddressID/FEIBusiness Operations
    MediNatura Inc102783016manufacture(62795-1017)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!